The Tim Ferriss Show

#385: The World's Largest Psychedelic Research Center

8 snips
Sep 10, 2019
Roland Griffiths, a behavioral biology professor and director at Johns Hopkins' new Center for Psychedelic and Consciousness Research, discusses groundbreaking research on psilocybin's therapeutic potential. Matthew Johnson, an expert in addiction, highlights psilocybin's promise in treating nicotine dependence. Together, they explore the ambitious goals of the center, including tackling PTSD, Alzheimer's, and more, while emphasizing the importance of meticulous scientific study and ethical considerations in psychedelic research.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
ANECDOTE

Personal Motivations

  • Tim Ferriss's family history includes Alzheimer's, Parkinson's, and treatment-resistant depression.
  • His best friend died from a fentanyl overdose, and his aunt died from Percocet and alcohol.
INSIGHT

Investing in Psychedelics

  • Tim Ferriss views psychedelic research like startup investments, seeking large, uncrowded bets with clear paths to progress.
  • He believes psychedelic science offers a large market (mental health), is uncrowded (lack of funding), and has a tractable path.
ANECDOTE

Catherine McCormick

  • Tim Ferriss cites Catherine McCormick's funding of oral contraceptive development as a model for philanthropic giving to science.
  • McCormick's $2 million investment, equivalent to $23 million today, significantly impacted history.
Get the Snipd Podcast app to discover more snips from this episode
Get the app